PharmaInsight
Drug ReviewsClinical ResearchRegulatory UpdatesPatient EducationIndustry NewsOpinion

Articles

Browse 1 published articles

AllDrug ReviewsClinical ResearchRegulatory UpdatesPatient EducationIndustry NewsOpinion
Opinion

Should India Reclassify Paracetamol? The Hepatotoxicity Debate

As paracetamol-related liver injuries rise in India, experts debate whether the world's most popular analgesic needs stricter regulatory controls.

Dr. Priya Sharma, PharmD, PhD Clinical Pharmacology
6 min12 March 2026
PharmaInsight

India's premier pharmaceutical knowledge platform. Evidence-based content for professionals and patients.

Categories

  • Drug Reviews
  • Clinical Research
  • Regulatory Updates
  • Patient Education

Company

  • About
  • Pricing
  • Write for Us

Legal

  • Terms of Service
  • Privacy Policy

Medical Disclaimer: Content on PharmaInsight is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making medical decisions.

© 2026 PharmaInsight. All rights reserved.